Drugmakers announce new price increase due to shortage of 120 drugs

WSJ has published an article analyzing the drug shortage emergency recently arisen in the US. As many as 120 drugs currently have availability issues, due to the supply restrictions for some active ingredients from China and some major “product recalls” involving Israel-based Teva, Mylan and China-based Zheijang Pharmaceuticals.